Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Amicus submits MAA seeking full European approval of Galafold for Fabry's disease

June 4, 2015

Catabasis Pharmaceuticals discloses PCSK9 inhibitors

June 4, 2015

Dual GHSR-NPY2R targeting peptides show promise for obesity treatment

June 4, 2015

OPKO files NDA for Rayaldee for secondary hyperparathyroidism in CKD

June 3, 2015

MatinasBioPharma's MAT-9001 superior to Vascepa in reducing blood lipid levels

June 3, 2015

Merck Serono signs collaboration agreement with Genea Biomedx for fertility technologies

June 2, 2015

Researchers describe the functional loss of HSD17B3 mutant G133R

June 2, 2015

European Commission approves intermittent use of Esmya for long-term management of uterine fibroids

May 29, 2015

Merck & Co. synthesizes antidiabetic FFAR1 agonists

May 29, 2015

The Scripps Research Institute receives NIH grant to study novel obesity pathway

May 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...